Beating Biopharma Manufacturing Bottlenecks with Raman Spectroscopy
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
False
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
By Martyn Williams
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
By Matt Sample
December 9, 2025
After a decade of preparation, the US pharmaceutical supply chain has seamless, serialized traceability for every prescription drug. Here are my lessons learned during that process.
3 min read
November 26, 2025
With new approvals for its denosumab biosimilars, Biocon Biologics is working to close gaps in access across Europe...
6 min read
October 31, 2025
The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.
3 min read
By Stephanie Vine, Julian Upton
October 27, 2025
Regulations are pushing companies to more environmentally friendly propellants, but how should capacity be scaled up?
5 min read
By Stephanie Vine
October 24, 2025
We speak with a biotech CEO about the potential of psychedelic medicine – and the challenges of working with stigmatized substances.
11 min read
By Stephanie Vine
October 23, 2025
Interviewing Quarraisha Abdool Karim – one of the world’s most influential HIV scientists
10 min read
October 22, 2025
Cell and gene therapy is advancing faster than ever, powered by breakthroughs in AI, automation, and CRISPR technology. But as some companies double down and others step back, the race to deliver real-world impact is intensifying.
4 min read
October 22, 2025
As tariffs and geopolitical uncertainty continue to disrupt supply chains, a new kind of biotech and pharma executive is emerging.
7 min read
False
False
False